Home > Browse Research > Life Sciences > Diagnostics > In Vitro Diagnostics

In Vitro Diagnostics: market research reports

In vitro diagnostic refers to all tests on human tissue where a specimen is taken from the body, as opposed to imaging, or in vivo, tests. The in vitro diagnostics industry plays an integral role in healthcare and disease management. Diagnostic laboratory technology has changed dramatically in the past few years, due to the publication of the human genome project and advances in functional genomics, bioinformatics, miniaturization and microelectronics.

Further the revolution in bioinformatics is allowing clinical and traditional medical engineering to blend with components derived from the information and computer sciences opening up new niche markets for POC test devices which will have a positive impact on diagnostic testing.

The IVD industry is on an upswing. For the past 15 years the number of assays introduced has been growing at a remarkable clip. At the same time, diagnostic laboratory technology is changing dramatically, due to the publication of the human genome project and advances in functional genomics, bioinformatics, miniaturization and microelectronics. Further the revolution in bioinformatics has allowed scientists to mine genetic information to derive new and hopefully better markers of some of the most pressing health problems such as cancer, cardiac disease, diabetes and autoimmune disorders. This has contributed to growth in many areas but especially in immunoassays and nucleic acid tests.

Blood Banking & Tissue Typing (264)

Cardiovascular (59)

Clinical Chemistry (259)

Clinical Laboratory Automation (5)

Clinical Laboratory Instrumentation (37)

Coagulation (340)

Companion Diagnostics (26)

General In Vitro Diagnostics (625)

Hematology & Oncology (509)

Histology & Cytology (310)

Immunoassays (174)

Lab Testing Services (29)

Microbiology & Virology (583)

Molecular Assays (64)

Molecular Diagnostics (293)

Over-the-Counter (71)

Point-of-Care (190)

Veterinary (18)

In Vitro Diagnostics market research reports and industry analysis

Lab Automation Market by Equipment & Software (Automated Liquid Handling & Robotics, Microplate Readers, LIMS and Automated Storage), and Applications (Drug Discovery, Clinical Diagnostics, Genomics, Proteomics) – Trends & Global Forecasts to 2017 6/14/2013 \| published by: MarketsandMarkets ... automation is defined as the use of technology to streamline or substitute manual manipulation of equipment and processes. Laboratory automation offers technologies and engineering backing for state-of-the-art work flows in research, quality assurance, and diagnostics ... \| read more...	$4,650.00
Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing) 6/13/2013 \| published by: Renub Research ... as well and slowly becoming the reality of future in the diagnostics industry By Technology Segment - Personalized Medicine diagnostics market is expected to grow with a double digit CAGR for the period of 2013 ... \| read more...	$1,400.00
Bioinformatics in IVD Testing 6/7/2013 \| published by: Kalorama Information ... test interpretation. This report, Bioinformatics in IVD Testing looks at the various IVD market segments where bionformatics is expected to have the most impact. Bioinformatics-based testing has made a huge contribution to cancer diagnosis ... \| read more...	$1,995.00
2013 Drugs of Abuse Testing in Germany: Hospitals, Commercial Labs, Physician Offices 6/7/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, ... \| read more...	$2,450.00
2013 Drugs of Abuse Testing in Italy: Hospitals and Commercial Labs 6/7/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, ... \| read more...	$2,450.00
2013 Drugs of Abuse Testing in Japan: Hospitals and Commercial Labs 6/7/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, ... \| read more...	$2,750.00
2013 Drugs of Abuse Testing in the US: Hospitals, Commercial Labs, Physician Offices 6/7/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, ... \| read more...	$3,500.00
2013 Drugs of Abuse Testing in the UK: Hospitals and Commercial Labs 6/7/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, ... \| read more...	$2,450.00
2013 Drugs of Abuse Testing in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers 6/7/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, ... \| read more...	$2,450.00
2013 Drugs of Abuse Testing in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers 6/7/2013 \| published by: Venture Planning Group ... 2013 Drugs of Abuse Testing in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, ... \| read more...	$6,500.00
2013 Drugs of Abuse Testing in France: Hospitals and Commercial Labs 6/7/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines,, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, ... \| read more...	$2,450.00
2013 Endocrine Function Testing Market in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers 6/6/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, ... \| read more...	$2,450.00
2013 Endocrine Function Testing Market in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers 6/6/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, ... \| read more...	$6,500.00
Companion Diagnostics Market, 2012-2023 6/6/2013 \| published by: Roots Analysis Pvt. Ltd. ... potential abnormalities and tailoring the treatment so as to make it as individualised as the disease itself. Targeted drugs have been fast to overshadow the traditional drugs, which favour the concept of one-size-fits-all. This has ... \| read more...	$1,699.00
2013 Endocrine Function Testing Market in the UK: Hospitals and Commercial Labs 6/6/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, ... \| read more...	$2,450.00
2013 Endocrine Function Testing Market in the US: Hospitals, Commercial Labs, Physician Offices 6/6/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, ... \| read more...	$3,500.00
2013 Endocrine Function Testing Market in France: Hospitals and Commercial Labs 6/6/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, ... \| read more...	$2,450.00
2013 Endocrine Function Testing Market in Germany: Hospitals, Commercial Labs, Physician Offices 6/6/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, ... \| read more...	$2,450.00
2013 Endocrine Function Testing Market in Italy: Hospitals and Commercial Labs 6/6/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, ... \| read more...	$2,450.00
2013 Endocrine Function Testing Market in Japan: Hospitals and Commercial Labs 6/6/2013 \| published by: Venture Planning Group ... The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, ... \| read more...	$2,750.00
2013 Therapeutic Drug Monitoring (TDM) Market in France: Hospitals and Commercial Labs 6/4/2013 \| published by: Venture Planning Group ... report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic ... \| read more...	$2,450.00
2013 Therapeutic Drug Monitoring (TDM) Market in Europe: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers 6/4/2013 \| published by: Venture Planning Group ... report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic ... \| read more...	$6,500.00
2013 Therapeutic Drug Monitoring (TDM) Market in Germany: Hospitals, Commercial Labs, Physician Offices 6/4/2013 \| published by: Venture Planning Group ... report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic ... \| read more...	$2,450.00
2013 Therapeutic Drug Monitoring (TDM) Market in Italy: Hospitals and Commercial Labs 6/4/2013 \| published by: Venture Planning Group ... report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic ... \| read more...	$2,450.00
2013 Therapeutic Drug Monitoring (TDM) Market in Spain: Hospitals, Commercial Labs, Ambulatory Care Centers 6/4/2013 \| published by: Venture Planning Group ... report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic ... \| read more...	$2,450.00

< prev 1 2 3 4 5 6 7 8 9 10 next >